| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insmed Inc (INSM) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 16 sells. INSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 243.9K | $24.92M | - | |
| Dir | 126.5K | $12.92M | - | |
| COO | 107.6K | $10.99M | - | |
| Other | 84.9K | $8.67M | - | |
| CEO | 81.4K | $8.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2018 | Lewis William49 | President &CEO | Buy | 15,700 | $15.90 | $249,600.17 | +11.6% | |
| May 30, 2018 | Schaeffer Orlov S Nicole46 | Chief People Strategy Officer | Sale+OE | 37,575 | $28.07 | $1,054,630.96 | -63.8% | |
| Nov 14, 2017 | Hayden Donald J Jr | Director | Sale+OE | 15,000 | $32.50 | $487,500.00 | -21.1% | |
| Sep 7, 2017 | Hayden Donald J Jr | Director | Sale+OE | 45,000 | $29.67 | $1,335,000.00 | -21.1% | |
| Sep 6, 2017 | Sharoky Melvin Md74 | Director | Sell | 50,000 | $27.37 | $1,368,697.54 | -3.9% | |
| May 31, 2017 | Pellizzari Christine A | General Counsel &Corp. Sec. | Buy | 10,000 | $15.14 | $151,382.00 | +21.1% | |
| Mar 1, 2017 | Drechsler Andrew T | Chief Financial Officer | Sale+OE | 20,000 | $16.51 | $330,200.00 | -80.0% | |
| Dec 15, 2016 | Pellizzari Christine A | General Counsel &Corp. Sec. | Buy | 20,000 | $12.81 | $256,100.00 | +200.0% | |
| Dec 14, 2016 | Potter Myrtle S | Director | Sell | 6,466 | $12.79 | $82,731.48 | -56.4% | |
| Nov 14, 2016 | Drechsler Andrew T | Chief Financial Officer | Sale+OE | 45,000 | $14.67 | $660,150.00 | -100% |